Showing results (1-10 of 413) with videos related to
Sort By:
Pageof 42
Expert Review of Hematology|August 12, 2014
Siltuximab for multicentric Castleman diseaseYi-Chang Liu, Katie Stone, Frits van RheeHematology/Oncology Clinics of North America|November 22, 2017
Treatment of Idiopathic Castleman DiseaseFrits van Rhee, Amy Greenway, Katie StoneBlood and Lymphatic Cancer : Targets and Therapy|May 26, 2015
Profile of elotuzumab and its potential in the treatment of multiple myelomaYi-Chang Liu, Susann Szmania, Frits van RheeClinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.Blood Reviews|December 13, 2023
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advancesEvan Lang, Frits van RheeCancer Treatment and Research|October 4, 2016
Transplantation for Multiple MyelomaYogesh S Jethava, Frits van RheeCytotherapy|December 22, 2010
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103Amberly Moreno-Bost, Susann Szmania, Katie Stone, et al.Blood|June 5, 2014
The future of autologous stem cell transplantation in myelomaFrits van Rhee, Sergio Giralt, Bart BarlogieLeukemia & Lymphoma|October 31, 2006
NY-ESO-1 immunotherapy for multiple myelomaSusann Szmania, Guido Tricot, Frits van RheePageof 42